Protocol Online logo
Top : Forum Archives: : Molecular Biology

B-catenin pathway - Lef/TCF-sensitive reporter gene assay (Sep/11/2008 )

Hi,

I'm reading papers on the wnt/beta catenin canonical pathway b/c my Phd research would involve b-catein and I'd like to clarify a few thoughts.

Investigators use the Lef/Tcf reporter gene assay to study the effect of silencing a component of teh wnt pathway (e.g. Dvl-1) on Lef/Tcf transcription. Why not just measure the b catenin expression? What's so significant of the Left/Tcf transription. Also, how does the Lef/Tcf reporter work? Does anyone have a link to its diagram?

Thanks

-Sarwat-

One of the reasons why people use the reporter assay is due to the fact that it is quite easy to quantify the result. If you want to look at b-ctn levels by Western blotting, this is not so quantitative as luciferase values. Additionally, the reporter assay, albeit an artificial method, is a measure for the activation of the pathway. The amount of b-ctn as such is not a guarantee for a high transcriptional activity, it's better to test it directly. A good alternative for this would be to measure the expression levels by qRT-PCR from a direct Wnt target gene (but this is more work than a simple luciferase assay).

I don't have a scheme for the assay, but actually it's just a plasmid with a luciferase reporter gene which is preceded by some TCF/Lef binding site (a.k.a. TOPFLASH), upon binding of TCF/Lef, the reporter gene is transcribed and can be measured.

I hope I have made some things clear, if not just let us know and I'll try again wink.gif

-dpo-

QUOTE (dpo @ Sep 13 2008, 03:01 AM)
One of the reasons why people use the reporter assay is due to the fact that it is quite easy to quantify the result. If you want to look at b-ctn levels by Western blotting, this is not so quantitative as luciferase values. Additionally, the reporter assay, albeit an artificial method, is a measure for the activation of the pathway. The amount of b-ctn as such is not a guarantee for a high transcriptional activity, it's better to test it directly. A good alternative for this would be to measure the expression levels by qRT-PCR from a direct Wnt target gene (but this is more work than a simple luciferase assay).

I don't have a scheme for the assay, but actually it's just a plasmid with a luciferase reporter gene which is preceded by some TCF/Lef binding site (a.k.a. TOPFLASH), upon binding of TCF/Lef, the reporter gene is transcribed and can be measured.

I hope I have made some things clear, if not just let us know and I'll try again wink.gif


Hi

Thank for your response. One more thing, why isn't the amount of b-ctn not a guarantee for a high transcriptional activity. Is it b/ c it can be produced by other pathways or it could simply correspond to the b-ctn residing in the cytoplasm and not the one actually transcribed as a result of an antagonist/agonist?

-Sarwat-

beta-catenin also binds to the cadherin complex at the plasma membrane, so you're also seeing this pool if you analyze the total amount of b-ctn. Based on the presence or absence of cell cell adhesion, the amount of b-ctn at the plasma membrane will differ. This b-ctn at the PM is not responsible for transcriptional activation, so you'll get a wrong estimate if you just use b-ctn amounts (although in some cases this may be enough when a luciferase assay isn't feasible, although I would then prefer to look at the levels of nuclear b-ctn).

-dpo-

Thnak you very much for the clarification, truly appreiated.

-Sarwat-